Head of Advanced Manufacturing Implementation, Purification Process Development
Sanofi
Michael joined the purification process development team at Sanofi in 2014 after receiving his PhD in 91成人短视频 and Biomolecular Engineering from Ohio State. Since joining Sanofi, he has led purification, drug substance, and CMC teams for a variety of molecules in Sanofi鈥檚 pipeline, ranging from monoclonal antibodies to enzyme replacement therapies for both early clinical and late-stage commercial programs. Michael has also been very active in Sanofi鈥檚 integrated continuous biomanufacturing (ICB) technology development efforts and is currently leading Sanofi鈥檚 end-to-end ICB team from the proof-of-concept phase to GMP implementation and commercialization.